Cresco Labs Inc.
CRLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $165 | $164 | $166 | $174 |
| % Growth | 0.8% | -1.3% | -5% | – |
| Cost of Goods Sold | $86 | $80 | $87 | $92 |
| Gross Profit | $79 | $83 | $79 | $83 |
| % Margin | 48.1% | 50.9% | 47.4% | 47.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $5 | $0 | $3 |
| SG&A Expenses | $59 | $58 | $65 | $42 |
| Sales & Mktg Exp. | $0 | $4 | $0 | $4 |
| Other Operating Expenses | $2 | $9 | $0 | $21 |
| Operating Expenses | $62 | $67 | $65 | $63 |
| Operating Income | $18 | $16 | $14 | $19 |
| % Margin | 10.8% | 9.9% | 8.2% | 11.1% |
| Other Income/Exp. Net | -$28 | -$13 | -$15 | -$16 |
| Pre-Tax Income | -$10 | $3 | -$1 | $3 |
| Tax Expense | $12 | $17 | $14 | $3 |
| Net Income | -$17 | -$16 | -$14 | -$4 |
| % Margin | -10.3% | -10% | -8.7% | -2.5% |
| EPS | -0.048 | -0.046 | -0.041 | -0.013 |
| % Growth | -3% | -12.2% | -226.2% | – |
| EPS Diluted | -0.048 | -0.046 | -0.041 | -0.013 |
| Weighted Avg Shares Out | 357 | 354 | 350 | 349 |
| Weighted Avg Shares Out Dil | 357 | 354 | 350 | 349 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $15 | $14 | $16 | $14 |
| Depreciation & Amortization | $15 | $14 | $15 | $16 |
| EBITDA | $20 | $31 | $29 | $32 |
| % Margin | 12% | 18.7% | 17.8% | 18.6% |